Clinical Trial Update: The Epigenetic Modification in OPRM1 on Postoperative Analgesia and Side Effect Induced by Sufentanil [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update investigating whether epigenetic modification of the mu-opioid receptor gene OPRM1 affects postoperative analgesia and sufentani…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Sufentanil (sufentanil)

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Epigenetics | Phase 4 | Status: UNKNOWN